Maricann CEO Says Cannabis Investors Should Focus on Western Europe

The United States is seeing rapid development of state-legal cannabis companies, and this has caught the attention of many investors seeking to capitalize on the growth of legal cannabis. Ben Ward, CEO of Canadian licensed producer Maricann Group (CSE: MARI) is optimistic about the developing market in the U.S., but he sees opportunity beyond the United States and Canada, especially in Europe.

In a contribution to CNBC, Ward suggested that there is a “global revolution” underway and points to the European Union’s much larger population as a reason to pay attention. He highlights Germany’s new medical cannabis program, which features health insurance coverage and pharmacy distribution as reasons Maricann is building up its European presence.

European markets are increasingly important to the cannabis sector. Each has a well-funded medical system, residents who seek natural and complementary therapies, and a government-supported mandate to stop the rising tide of opiate addiction related to chronic pain treatment.

Read Ben Ward’s “Forget the US. Here’s where medical marijuana is really taking off”:

Get ahead of the crowd by signing up for 420 Investor when it becomes available again. It’s the largest & most comprehensive premium service for cannabis investors since 2013.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter